An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway

M A Olayioye1, A Badache, J M Daly

  • 1Friedrich Miescher Institute, Basel, CH-4002, Switzerland.

Insights

Src kinase is crucial for rapid mitogen-activated protein kinase (MAPK) activation by epidermal growth factor (EGF) and neuregulins (NRGs) in breast cancer cells. This pathway is vital for gene transcription, highlighting a novel signaling route.

Area of Science:

  • Cellular signaling pathways
  • Receptor tyrosine kinases
  • Cancer biology

Background:

  • ErbB receptor tyrosine kinases are activated by ligands like EGF and neuregulins (NRGs).
  • Activation stimulates intracellular pathways, including the mitogen-activated protein kinase (MAPK) cascade.
  • The role of Src kinase in this rapid activation is not fully understood.

Purpose of the Study:

  • To investigate the role of Src kinase in EGF- and NRG-induced MAPK activation.
  • To elucidate the molecular mechanisms by which Src influences ErbB signaling.
  • To determine the impact of Src inhibition on downstream transcriptional events.

Main Methods:

  • Utilized breast carcinoma cell lines (T47D and SKBR3).
  • Employed a pharmacological inhibitor (CGP77675) specific for Src family kinases.
  • Assessed MAPK activation, Shc phosphorylation, and receptor-ligand interactions.
  • Monitored transcription from a MAPK-responsive promoter.

Main Results:

  • Src kinase is essential for rapid MAPK activation by EGF and NRG at low ligand concentrations.
  • Inhibition of Src kinase transiently blocked ligand-induced MAPK activation and suppressed transcription.
  • Src inactivation impaired ligand-induced Shc phosphorylation but did not affect Shc-ErbB association or receptor-bound Shc phosphorylation.

Conclusions:

  • ErbB signaling utilizes a novel, Src-dependent pathway for rapid MAPK activation.
  • Src kinase plays a critical role in initiating the signaling cascade that leads to transcriptional changes.
  • This finding reveals a new mechanism for regulating ErbB-mediated cellular responses in breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...